234 related articles for article (PubMed ID: 10765469)
1. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
Ofoefule SI; Chukwu A
Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
[TBL] [Abstract][Full Text] [Related]
2. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
3. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
[TBL] [Abstract][Full Text] [Related]
5. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
Kadam VD; Gattani SG
Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
[TBL] [Abstract][Full Text] [Related]
7. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
[TBL] [Abstract][Full Text] [Related]
8. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic matrices: application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release.
El-Malah Y; Nazzal S
Int J Pharm; 2006 Feb; 309(1-2):163-70. PubMed ID: 16413978
[TBL] [Abstract][Full Text] [Related]
10. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
Emeje MO; Kunle OO; Ofoefule SI
Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
[TBL] [Abstract][Full Text] [Related]
11. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices.
Tatavarti AS; Mehta KA; Augsburger LL; Hoag SW
J Pharm Sci; 2004 Sep; 93(9):2319-31. PubMed ID: 15295792
[TBL] [Abstract][Full Text] [Related]
12. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
Zhang F; Meng F; Wang ZY; Na W
Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
[TBL] [Abstract][Full Text] [Related]
13. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
Kadam VD; Gattani SG
Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
[TBL] [Abstract][Full Text] [Related]
14. [Effect of EUDRAGIT® RS on the release behaviour of theophylline solid dispersions].
Orugun O; Oyi A; Olowosulu A; Apeji Y; Olayemi O
Ceska Slov Farm; 2016; 65(6):226-231. PubMed ID: 28079388
[TBL] [Abstract][Full Text] [Related]
15. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
[TBL] [Abstract][Full Text] [Related]
16. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
[TBL] [Abstract][Full Text] [Related]
17. Development of matrix-based theophylline sustained-release microtablets.
Rey H; Wagner KG; Wehrlé P; Schmidt PC
Drug Dev Ind Pharm; 2000 Jan; 26(1):21-6. PubMed ID: 10677806
[TBL] [Abstract][Full Text] [Related]
18. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Ghanam D; Kleinebudde P
Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of matrix and two layered sustained release suppositories of theophylline.
Maity S; Sa B; Bandyopadhyay AK
Boll Chim Farm; 2001; 140(6):462-6. PubMed ID: 11822240
[TBL] [Abstract][Full Text] [Related]
20. Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery.
Pringels E; Ameye D; Vervaet C; Foreman P; Remon JP
J Control Release; 2005 Apr; 103(3):635-41. PubMed ID: 15820410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
